Nutra News made Easy
Pep19 (DIIADDEPLT) is a novel, orally active peptide identified as an inverse agonist of the cannabinoid type 1 (CB1) receptor, showing promising dual-action benefits in metabolic health and sleep quality. In a 60-day, triple-blind, placebo-controlled clinical trial involving obese adults (BMI 30–35), daily supplementation with 5 mg Pep19 led to a significant 17% reduction in… Read More
CaffShock® is a natural, synergistic blend supported by pre-clinical studies focused on thermogenesis and weight management. In vitro studies demonstrate its potential to reduce triglyceride accumulation in pre-adipocyte cells, even under high-calorie conditions. The findings highlight CaffShock®’s ability to support fat metabolism and prevent fat storage. Additionally, it exhibits thermogenic properties that help increase energy… Read More
The study determined that adding jamun (Syzygium cumini) to the diet significantly reduced the risk of estrogen-induced breast cancer in rats. Jamun delayed the appearance of tumors, lowered the number and size of tumors, and reduced hormone levels like estradiol and prolactin. It also decreased cell proliferation markers such as ER-α and Cyclin D1, while… Read More
A new clinical study from Italian researchers has demonstrated that a botanical-based oral supplement containing Venerinase a patented blend of Rhodiola rosea, Tribulus terrestris, Moringa oleifera, and Undaria pinnatifida combined with folic acid, B vitamins, zinc, and magnesium, may offer significant anti-aging and anti-inflammatory benefits for the skin. In a randomized, single-blind trial involving 40… Read More
InnoSlim®, developed by NuLiv Science, has been shown through in-vitro, in-vivo, and human studies to regulate glucose, fat cell, and muscle metabolism. It reduces glucose absorption while enhancing fat burning and muscle glucose uptake. These findings suggest that InnoSlim® may be effective in supporting weight management and addressing metabolic syndrome. Source: http://www.innoslim.com/ Read More